Clinical Trials in New York

Showing 8181-8200 of 17,259 trials

Romidepsin Plus 3BNC117 Phase 2a Study

NCT02850016

The aim of this protocol is to evaluate the effects of romidepsin plus 3BNC117 or romidepsin alone on delaying or preventing viral rebound in ART-treated HIV-1-infected individuals during an analytical interruption of ART.

Human Immunodeficiency Virus (HIV)

Rockefeller University48 participantsStarted Jan 2017

New York, New York, United States • Aarhus, Denmark • Cologne, Germany

COMPLETEDPhase 2< 1 mile

An Exploratory Maintenance Trial of BI 655064 in Patients With Lupus Nephritis

NCT03385564

The main objectives of this trial are to evaluate the long term efficacy and safety of different doses of BI 655064 versus placebo as add-on therapy to Standard of Care (SOC) during maintenance therapy for lupus nephritis.

Lupus Nephritis

Boehringer Ingelheim69 participantsStarted Jan 2018

Plantation, Florida, United States • Great Neck, New York, United States • Manhasset, New York, United States +33 more locations

Romidepsin Plus 3BNC117 Phase 2a Study

An Exploratory Maintenance Trial of BI 655064 in Patients With Lupus Nephritis

Find Trials by Condition in New York

A Study to Evaluate Androderm®'s Effect on Blood Pressure in Adult Hypogonodal Male Participants

Safety Study of Gene Modified Donor T-cells Following Partially Mismatched Stem Cell Transplant

Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD

A Study of Taselisib + Fulvestrant Versus Placebo + Fulvestrant in Participants With Advanced or Metastatic Breast Cancer Who Have Disease Recurrence or Progression During or After Aromatase Inhibitor Therapy

BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma

Dose-ranging Efficacy and Pharmacokinetics Study of Intravenous Atorvastatin in Hypercholesterolemic Patients

Evaluation of Implantable Tibial Neuromodulation (TITAN 1) Feasibility Study

An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Adults With Rheumatoid Arthritis

A Multi-centre Study to Assess the Safety, Tolerability, and Pharmacokinetics of Capivasertib (AZD5363) in Combination With Novel Agents in Patients With Metastatic Prostate Cancer

INGEVITY+ Active Fixation Pace/Sense Lead Clinical Study

Study of Bevacizumab and Erlotinib in Patients With Advanced Non-small Cell Lung Cancer

A Safety and Efficacy Extension Study of a Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Patients With Hemophilia B

Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus Cisplatin

Longitudinal Protocol for Granulomatosis With Polyangiitis (Wegener's) and Microscopic Polyangiitis

Determining Disease Activity Biomarkers in Individuals With Polyarteritis Nodosa

OGX-427 in Metastatic Castrate-Resistant Prostate Cancer With Prostate-Specific Antigen Progression While Receiving Abiraterone

ANAVEX2-73 for Treatment of Early Alzheimer's Disease

Drug-Drug Interaction Study of HBI-3000 and Paroxetine in Healthy Adult Male and Female Subjects